Recent developments in neuronal nicotinic acetylcholine receptor antagonists

Expert Opinion on Therapeutic Patents

Volumn 10, Issue 10, 2000, Pages 1561-1581

  Dwoskin, L P ^a   Xu, R ^a   Ayers, J T ^a   Crooks, P A ^a  

^a University of Kentucky   (United States)

Author keywords

Acetylcholine receptor; Alzheimer's disease; Anabaseine; Anabasine; Conotoxin; Dihydro erythroidine; Drug abuse; GTS 21; Lobeline; Mecamylamine; NDNI; Neuronal nicotinic cholinergic channel blockers; Nicotine; NONI; Parkinson's disease

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ALKALOID; ALKENYL GROUP; ALKYL GROUP; ALPHA BUNGAROTOXIN; ALPHA CONOTOXIN; CARBON; CHLORISONDAMINE; CONOTOXIN; CYTISINE; DIHYDRO BETA ERYTHROIDINE; DITERPENE; DIZOCILPINE; EPIBATIDINE; LIGAND; LOBELINE; MECAMYLAMINE; METHYLLYLCACONITINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE; NICOTINE DERIVATIVE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PYRIDINE DERIVATIVE; PYRROLIDINE DERIVATIVE; PYRROLIZINE DERIVATIVE; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; CENTRAL NERVOUS SYSTEM; CHANNEL GATING; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG SELECTIVITY; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUMAN CELL; MEDICAL LITERATURE; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PAIN; PARKINSON DISEASE; PATENT; PERIPHERAL NERVOUS SYSTEM; PROTEIN LOCALIZATION; REVIEW;

EID: 0033820715     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.10.10.1561     Document Type: Review

References (126)

1. Neuronal nicotinic acetylcholine receptors as novel drug targets
2. The diversity of neuronal nicotinic acetylcholine receptors
3. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebra neurons
4. Presynaptic nicotinic acetylcholine receptors
5. Synaptic potential mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons
6. Primary structures of beta- and delta-subunit precursors of Torpedo californica acetylcholine receptor deduced from cDNA sequences
7. Acetylcholine receptor: An allosteric protein
8. Structure of nicotinic acetycholine receptors
9. Neuronal nicotinic receptors: Molecular organization and regulations
10. Evidence that the M2 membrane-spanning region lines the ion channel pore of the nicotinic receptor
11. Nucleotide and deduced amino acid sequences of Torpedo californica acetylcholine receptor γ-subunit
12. Brain nicotinic receptors: Structure and regulation, role in learning and reinforcement
13. Pharmacology of neuronal nicotinic acetylcholine receptor subtypes
14. β-Subunits co-determine the sensitivity of rat neuronal nicotinic receptors to antagonist
15. Molecular evolution of the nicotinic acetylcholine receptor: An example of multigene family in excitable cells
16. Evolutionary history of the ligand-gated ion-channel superfamily of receptors
17. Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure
18. Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor
19. Mapping of ligand binding sites of neuronal nicotinic acetylcholine receptors using chimeric alpha subunits
20. Both α- and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors
21. Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors
22. Diversity in primary structure and function of neuronal nicotinic acetycholine receptor channels
23. An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells
24. A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX
25. Comparative pharmacology of epibatidine: A potent agonist for neuronal nicotinic acetylcholine receptors
26. The α5 gene product assembles with multiple acetylcholine receptor subunits to form distinctive receptor subtypes in brain
27. Three subtypes of alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors are expressed in chick retina
28. Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes
29. Functional contributions of α5 subunit to neuronal acetylcholine receptor channels
30. Formation of oligomers containing the β3 and β4 subunits of the rat nicotinic receptor
31. Neuronal nicotinic acetylcholine receptors on bovine chromaffin cells: Cloning, expression and genomic organization of receptor subunits
32. Heteromeric complexes of α5 and/ or α7 subunits. Effects of calcium and potential role in nicotine-induced presynaptic facilitation
33. Heterogeneity of nicotinic receptor class and subunit mRNA expression among individual parasympathetic neurons from rat intracardiac ganglia
34. Brain α-bungarotoxin binding protein, cDNAs and Mabs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily
35. Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo-interpeduncular system
36. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations
37. α4-2β2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs
38. Regions of beta4beta2 subunit chimera that contribute to the agonist selectivity of neuronal nicotinic receptors
39. The kinetic properties of neuronal nicotinic receptors: Genetic basis and functional diversity
40. The beta subunit of neuronal nicotinic acetylcholine receptors is a determinant of the affinity for substance P inhibition
41. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes
42. Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor βsubunits
43. Structurally different neuronal nicotinic acetylcholine receptor subtypes purified and characterized using monoclonal antibodies
44. Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies
45. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment
46. Distribution of alpha2, alpha3, alpha4 and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat
47. 125I]-alpha bungarotoxin
48. Nicotine binding sites in rat and mouse brain: Comparison of acetylcholine, nicotine and alphabungarotoxin
49. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine
50. Abnormal avoidance learning in mice lacking functional high affinity nicotinic receptors in the brain
51. Identification of four classes of brain nicotinic receptors using beta-2 mutant mice
52. α-Bungarotoxin-sensitive nicotinic receptors on bovine chromaffin cells: Molecular cloning, functional expression and alternative splicing of the α7 subunit
53. Expression of α7 neuronal nicotinic receptors during postnatal development of the rat cerebellum
54. Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and fast nicotinic currents
55. Properties of putative nicotine receptors identified on cultured cortical neurons
56. α-Bungarotoxin receptors contain α7 subunits in two different disulfide-bonded conformations
57. Neuronal bungarotoxin blocks the nicotinic stimulation of dopamine release from rat striatum
58. 3H]dopamine release from synaptosome prepared from mouse striatum
59. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors
60. 3H]dopamine release in rat striatal slices via glutamate release
61. 3H]dopamine release by pyridino N-substituted nicotine analogues: A new class of nicotinic antagonist
62. α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes
63. 3H]dopamine release from striatal synaptosomes: Pharmacological characterization
64. UB-165: A novel nicotinic agonist with subtype selectivity implicates the alpha4beta2(*) subtype in the modulation of dopamine release from rat striatal synaptosomes
65. β3: A new member of nicotinic acetylcholine receptor gene family is expressed in brain
66. Gene transcripts from the nicotinic acetylcholine receptor subunit, beta4, are distributed in multiple areas of the rat central nervous system
67. Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantial nigra and ventral tegmental area
68. Ultrastructure localization of the alpha4 subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra
69. Neuronal nicotinic receptor α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain
70. Immunohistochemical localization of the nicotinic acetylcholine receptor subunit α6 to dopaminergic neurons in the substantia nigra and ventral tegmental area
71. Stable expression, pharmacologic properties and regulation of human nicotinic acetylcholine α4β2 receptor
72. Similarity between rat brain nicotinic α-bungarotoxin receptors and stably expressed α-bungarotoxin binding sites
73. Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor
74. 3H]-methyllycaconitine in the mouse brain
75. 3H]methyllycaconitine: A new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors
76. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain
77. 125I-alpha-conatoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain
78. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes
79. The correction of α7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes
80. α7 receptor-selective agonists and modes of α7 receptor activation
81. Molecular cloning, functional, properties and distribution of rat brain α7: A nicotinic cation channel highly permeable to calcium
82. Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line
83. ABT-594 [(R)-5-(2-azetidinyl methoxy)-2-chloropyridine]: A novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization
84. Human neuronal nicotinic receptors
85. The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion
86. Blockade of cholinergic channels by chlorisondamine on a crustacean muscle
87. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist
88. 3H]Mecamylamine binding to rat brain membranes
89. Pharmacological evaluation of the antagonism of nicotine's central effects by mecamylamine and pempidine
90. 3H](-)-nicotine binding in rat cortex
91. Nicotine-induced increase in the neuronal nicotinic receptors results from a decrease in the rate of receptor turnover
92. Mecamylamine is a selective non-competitive antagonist of N-methyl-D-aspartate and aspartate-induced currents in horizontal cells dissociated from the catfish retina
93. 3H]MK801 binding to the N-methyl-D-aspartate receptor reveals drug interactions with zinc and magnesium binding sites
94. 3H-[1-(2-thienyl) cyclohexyl]-piperidine) binding in rat hippocampus
95. 3H]MK-801 to brain membranes, but not via the stimulation of high-affinity nicotinic receptors
96. 3H](-)nicotine to rat brain membranes and its inhibition by analogues of nicotine
97. Design, synthesis and biological evaluation of substituted benzoate analogs of the selective nicotinic acetylcholine receptor antagonist, methyllycaconitine
98. A autoradiographic study of the distribution of binding sites for the novel the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain
99. Ring E analogs of methyllycaconitine (MLA) as novel nicotinic antagonists
100. Neuronal nicotinic acetylcholine receptors as targets for drug discovery
101. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes
102. Development of a novel class of subtype-selective nicotinic receptor antagonist: Pyridine-N-substituted nicotine analogs
103. 3H]dopamine from superfused rat striatal slices
104. Interaction of DMXBA (GTS-21), a cognition enhancing compound, with cholinergic receptors
105. Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for CNS therapeutics
106. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
107. Self-administered nicotine activates the mesolimbic dopaminergic system through the ventral tegmental area
108. Nicotine self-administration in rats
109. Acquision of nicotine self- administration in rats: The effects of dose, feeding schedule and drug contingency
110. Nornicotine is self-administered intravenously by rats
111. Reinforcing effects of nicotinic compounds: Intravenous self- administration in drug naive mice
112. Behavioral and pharmacokinetic studies on nicotine, cytisine and lobeline
113. The effect of nicotine on locomotor activity in non-tolerant and tolerant rats
114. Pharmacological characterization of nicotine-induced place preference
115. Nicotine induced place preference following prior nicotine exposure in rats
116. Dissociation between the locomotor stimulant and depressant effects of nicotinic agonists in rats
117. 3H]dopamine uptake
118. 86Rb+ efflux from thalamic synaptosomes
119. Structure-activity study of RJR-2429 analogs: Development of selective ligands for nicotinic acetylcholine receptors
120. Single-residue alteration in α-conotoxin PnIA switches its NAChR subtype selectivity
121. α-Conotoxin EpI, a novel sulfated peptide from Conus episcopatus that selectively targets neuronal nicotinic acetycholine receptors
122. Single amino acid substitutions in α-Conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor
123. Recent developments in neuronal nicotinic acetylcholine receptor modulators
124. Targeting nicotinic acetylcholine receptors: Advances in molecular design and therapies
125. Exploring the nature of molecular recognition in nicotinic acetylcholine receptors
126. Nicotinic cholinergic receptor pharmacophores